 Tags:
cancer |
|
|
|
|
|
|
« Back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 Next » |
|
»
Patients With Advanced Hepatitis C And Diabetes Have Twice The Risc For Liver CANCER
Published 2008-06-09
|
| 
Patients who have chronic hepatitis C with advanced fibrosis have twice the risk of developing liver cancer if they also have diabetes.
|
»
Androgen-independent Prostate CANCER Treated With Novel Chemo Drug
Published 2008-06-09
|
| 
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers.
|
»
Oral CANCER, Chronic Pediatric Ear Infections And Hearing Health Refected In New Study
Published 2008-06-09
|
| 
Three new studies published in the June 2008 edition of Otolaryngology -- Head and Neck Surgery focus on what role gender plays in the prognosis of oral tongue cancer, chronic ear infections in children, and the success rates of hearing aid implants in the elderly.
|
»
Kylie Minogue had been a great ambassador for breast CANCER awareness
Published 2008-06-09
|
| 
Kylie's breast cancer triggered a surge of over 30 per cent in breast imaging of low risk women, says new University of Melbourne study.
|
»
Tumor Suppressor Gene Could Be a New Target For Future AntiCANCER Drugs
Published 2008-06-09
|
| 
Scientists at Cold Spring Harbor Laboratory (CSHL) have taken the search for cancer-causing genes an important step forward. In a newly published paper, they confirm that a gene called DLC1 is a tumor suppressor. They have demonstrated in living mice that its deletion, inactivation or loss precipitates events culminating in an aggressive type of liver cancer closely related to common human epithelial cancers of the liver (also known as hepatocellular carcinoma, or HCC).
|
»
The Cost-Benefit Of Beginning Screening At An Earlier Age In Colon CANCER
Published 2008-06-08
|
| 
The prevalence of pre-cancerous masses in the colon is the same for average-risk patients who are 40 to 49 years of age and those who are 50 to 59 years of age, reports a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
|
»
Smokers May Be Protected From Lung CANCER Eating Fruits, Vegetables And Teas
Published 2008-06-08
|
| 
Tobacco smokers who eat three servings of fruits and vegetables per day and drink green or black tea may be protecting themselves from lung cancer, according to a first-of-its-kind study by UCLA cancer researchers.
|
»
The behaviour of magnetic nanoparticles used for CANCER therapy
Published 2008-06-08
|
| 
A measuring procedure developed in the Physikalisch-Technische Bundesanstalt (PTB) can help to investigate in some detail the behaviour of magnetic nanoparticles which are used for cancer therapy.
|
»
Colorectal CANCER Survival Related With Sex, Age And Ethnicity
Published 2008-06-08
|
| 
The interaction of sex, age and ethnicity has a significant impact on overall survival in metastatic colorectal cancer (MCRC) patients, a study led by researchers at the University of Southern California (USC) and USC/Norris Comprehensive Cancer Center suggests.
|
»
PAHs, via oxidative stress, can led to mutations in critical genes important in lung CANCER
Published 2008-06-08
|
| 
Two types of cancer-causing agents in cigarettes--a nicotine-derived chemical and polycyclic aromatic hydrocarbons (PAHs) are the main culprits in lung cancer. Exposure to tobacco smoke -- both mainstream and second-hand -- is a leading cause of cancer death in the United States.
|
»
Chronic myelogenous leukemia cells Killed by combination of new anti-CANCER drugs
Published 2008-06-08
|
| 
Virginia Commonwealth University Massey Cancer Center researchers have identified that a combination of novel anti-cancer compounds is able to kill chronic myelogenous leukemia cells previously resistant to conventional forms of therapy.
|
»
Enzyme to be altered to design CANCER-fighting drugs
Published 2008-06-08
|
| 
A critical enzyme used to prepare a powerful cancer-killing agent may be able to help drug makers better target the cells the natural product attacks, according to findings published in the May 23 edition of the Journal of Biological Chemistry.
|
»
Increased pathologic complete response rates in diabetic breast CANCER patients taking Metformin
Published 2008-06-08
|
| 
Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential cancer therapy, according to researchers at The University of Texas M. D. Anderson Cancer Center.
|
»
10 To 15 Percent Of All CANCERs To Benefit Of New Immunization Strategy
Published 2008-06-07
|
|
Immunization against “false” proteins could sensitize the immune system against tumour cells.
|
»
Risk Of Lung CANCER Among Nonsmokers Because Of Common Gene Disorder
Published 2008-06-07
|
| 
Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers.
|
»
CANCER-detecting Nanoparticles are important in MRI detection
Published 2008-06-07
|
| 
Magnetic resonance imaging (MRI) can be a doctor's best friend for detecting a tumor in the body without resorting to surgery. MRI scans use pulses of magnetic waves and gauge the return signals to identify different types of tissue in the body, distinguishing bone from muscle, fluids from solids, and so on.
|
»
A study could change the direction of research into CANCER stem cell biology
Published 2008-06-07
|
| 
The molecular profile of cancer stem cells that initiate metastatic colon tumors is significantly different from those responsible for primary tumors, according to new research from a team at Weill Cornell Medical College.
|
»
Large gaps in CANCER Survivors Care
Published 2008-06-07
|
| 
Many long-term survivors of cancer are not receiving the necessary symptom management that they require to help them live with the consequences of their disease, its treatment, or both, according to a leading professor of palliative medicine.
|
»
Survival For End-stage Head And Neck CANCER Increased by Gene Therapy
Published 2008-06-07
|
| 
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced May 28 at the American Society of Gene Therapy annual meeting in Boston.
|
»
Hormone estrogen is a key player in about half of all prostate CANCERs
Published 2008-06-07
|
| 
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers.
|
|
|
« Back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 Next » |
